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Abstract
Background: We investigated whether polymorphism rs7555523 (A > C) in human transmembrane and coiled-coil
domain 1 (TMCO1) gene is a risk factor for primary open angle glaucoma (POAG) in a Saudi cohort.
Methods: A cohort of 87 unrelated POAG cases and 94 control subjects from Saudi Arabia were genotyped
using Taq-Man® assay. The association of genotypes with POAG and other glaucoma specific clinical indices
was investigated.
Results: The genotype and allele frequency of polymorphism rs7555523 at TMCO1 did not show any
statistically significant association with POAG as compared to controls. The minor allele frequency was 0.103
in cases and 0.085 in controls. Except for awareness of glaucoma (p = 0.036), no significant association of
genotypes were seen with glaucoma specific clinical indices such as intraocular pressure (IOP), cup/disc ratio
and number of anti-glaucoma medications used. Binary logistic regression analysis (adjusted for age and
gender) showed that age was a significant indicator for the development of glaucoma in this group (adjusted
odds ratio = 1.2; 95 % confidence interval = 1.078–1.157; p < 0.001).
Conclusion: Our study was unable to replicate the findings of previously reported association for
polymorphism rs7555523 in TMCO1 with POAG and related clinical indices such as IOP and cup/disc ratio
indicating that this variant is not a risk factor for POAG in the Saudi cohort.
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Background
Glaucoma, a neurodegenerative disease is characterized
by progressive damage of retinal ganglion cells (RGCs)
resulting in characteristic cupping of the optic nerve
head and loss of peripheral vision [1]. Primary open
angle glaucoma (POAG) is the second most common
form of glaucoma in Saudi Arabia which is clinically
characterized by an open and normal anterior iridocor-
neal chamber angle [2]. Aging, gender, African ancestry,
family history, elevated intraocular pressure (IOP),
central corneal thickness, and myopia are some of the
well-recognized risk factors associated with POAG
pathogenesis [3]. Although POAG is clinically well-
defined, the biological basis of the disease is not well
understood and factors contributing to its progression
are not fully characterized.
Genetic studies represent an important tool to identify
genes and molecular pathways involved in disease pa-
thogenesis. POAG is genetically complex with largely
polygenic and multifactorial inheritance [4]. Using a
genome-wide and candidate gene approach, population-
based genetic studies have identified several genes and
genetic variants associated with POAG and related
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quantitative endophenotype traits [5]. A genome-wide
association study (GWAS) in Australians of European
descent identified a susceptibility locus at transmem-
brane and coiled-coil domains 1 (TMCO1) [6]. van
Koolwijk et al. performed a GWAS for IOP in POAG
patients of European descent and identified single
nucleotide polymorphism (SNP) 7555523, located in
TMCO1 suggesting a role in IOP regulation [7]. TMCO1
gene is located 7.6 MB upstream of the known POAG
gene, myocilin C (MYOC), on chromosome 1q24.1. It
encodes a transmembrane protein with a coiled-coil
domain that may localize to the Golgi apparatus and
endoplasmic reticulum or to the mitochondria in differ-
ent cell types with a plausible role in apoptosis of RGCs
[6, 8]. TMCO1 is highly expressed in the human ciliary
body, trabecular meshwork and retina [7, 9, 10]. How-
ever, precise role of TMCO1 in POAG pathogenesis is
still unclear.
So far, there are no published reports of association
studies at the TMCO1 locus in the Middle East popu-
lation. In the current study, we investigated the asso-
ciation of TMCO1 SNP rs7555523 with POAG in a
Saudi cohort.
Methods
Study design and setting
This case–control genetic association study was con-
ducted between November 2015 through February 2016
at King Abdulaziz University Hospital, King Saud Uni-
versity, Riyadh, Saudi Arabia.
Study population
We recruited 87 Saudi adult-POAG patients who satis-
fied strict the following clinical criteria: i) appearance
of the disc or retinal nerve fiber layer e.g., thinning or
notching of disc rim, progressive changes, nerve fiber
layer defect; ii) presence of characteristic abnormalities
in visual field (e.g., arcuate scotoma, nasal step, para-
central scotoma, generalized depression) in the absence
of other causes or explanation; iii) age >40 years, and
iv) open anterior chamber angles bilaterally on gonio-
scopy. Exclusion criteria included evidence of second-
ary glaucoma, e.g., pigmentary dispersion syndrome,
pseudoexfoliation, history of steroid use, or ocular
trauma. All cases had onset of glaucoma after age 40
(adult onset POAG). Patients were recruited from the
glaucoma clinic at King Abdulaziz University Hopsital
after signing an informed consent approved by the
institutional review board (proposal number # 08–657).
A second group healthy controls (n = 94) of Saudi
origin and free from glaucoma by examination were
recruited. Inclusion criteria included: >40, normal IOP,
open angles on gonioscopy and normal optic nerves
upon examination.
Genotyping
Genotyping of intronic polymorphism, rs7555523 (g.16
5718979A > C), of the TMCO1 gene (NC_000001.10)
was performed using the TaqMan® SNP Genotyping
assay ID: C_29621671_10 (Applied Biosystems Inc.,
Foster City, CA, USA) on ABI 7500 real-time PCR
system (Applied Biosystems). Each PCR reaction was
performed in a 96-well plate in a total volume of 25 μL
consisting of 1X TaqMan® Genotyping Master Mix
(Applied Biosystems), 1X SNP Genotyping Assay Mix,
20 ng DNA, and two no template (negative) controls
under cycling conditions recommended by the manufac-
turer [11]. Genotypes of TMCO1 rs7555523 SNP were
identified using the automated 2-color allele discrimin-
ation software on ABI 7500 on a two-dimensional graph.
Statistical analysis
The continuous variables were presented as mean (± Stand-
ard Deviation, SD) and tested by Student’s t-test. Cat-
egorical variables were presented as frequencies and
percentages. Hardy-Weinberg Equilibrium (HWE) de-
viation was tested by Pearson’s Chi2 test. Odds ratio
(OR) was calculated and Chi2 test was used to detect
any association between different characteristics and
the genetic profiles (Fisher Exact test when applicable).
Mann–Whitney U test was used to investigate whether
there was any significant difference between the genotypes
and clinical variables. The confidence interval (CI) level
was set to 95 % and a p value below 0.05 was considered
statistically significant. Data were analyzed using SPSS®
version 22.0 (IBM Inc., Chicago, Illinois, USA).
Results
In the current study we recruted 87 adult-POAG pati-
nets with confirmed diagnosis as POAG and a matching
group of 94 subjects that served as controls after a
confirmed clinical examination that identified them as
“glaucoma free”, see methods.
As shown in Table 1 cases had a mean age of 61.1 years
(ranging from 43 to 74 years) where 52 (59.8 %) of them
were male and 35 (40.2 %) were female. On the other
hand, controls showed a mean age of 56.5 years (range
45–70 years) where 69 (73.4 %) of them were male and
25 (26.6 %) were female. Despite the fact that males
were more than females in both study groups, this
diffrence was not statastcalliy significant. No sig-
nificant difference was observed between cases and
controls in terms of all demographic, systemic co-
morbidity and glaucoma specific indices except for the
family history of glaucoma and awareness of having
glaucoma (p = 0.006 and <0.0001, respectively).
The genotype frequencies in both the cases and
control groups did not deviate significantly from the
HWE (p > 0.05). The wildtype genotype (A/A) was
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predominant in both cases and controls (n = 69 (79.3 %)
and n = 78 (83 %), respectively) with a slightly increased
frequency of heterozygous (C/A) genotype in cases (18;
20.7 %) versus controls (16; 17 %). No homozygous mu-
tant genotype (C/C) was observed in both the groups. The
cases were 1.3 times more likely to encounter a variation,
however, the distribution was non-significant (OR = 1.3;
95 % CI = 0.563–2.891; p = 0.571). Likewise, the same ef-
fect was detected while comparing the frequency of the
wildtype “A” allele to the mutated “C” allele, with a similar
OR (1.3) and a non-significant p value (0.591). The geno-
type and allele frequency distribution is shown in Table 2.
Furthermore, we evaluated the effect of genotype on
demographic, systemic diseases and glaucoma specific
indices among POAG cases as demonstrated in Table 3.
Although there was a preponderance of male subjects in
both the genotype groups and the subjects with A/C
genotypes were found to be slighter younger but there
was no statistically significant difference in terms of age
(p = 0.644) and gender (p = 0.421). Similarly, except for
awareness of having glaucoma variable (p = 0.036), no
statistically significant difference was observed in terms
of systemic diseases and health awareness/ behavior
characteristics. However, more importantly, none of the
glaucoma specific indices such as IOP, cup/disc ratio
and number of anti-glaucoma medications showed
any statistically significant difference between the two
genotype groups.
In addition, to investigate the effect of harboring a
mutated genotype on having glaucoma, we performed a
binary logistic regression analysis (adjusted for age and
gender). The analysis showed that patients with mutated
genotype seems to be 1.3 times more likely to get
the disease (POAG), however, the OR was not found
to be statistically significant (adjusted OR = 1.3; 95 %
CI = 0.534–3.261; p = 0.548). Nevertheless, adjustment
of age and gender revealed that although non-significant,
females were 1.6 times more likely to get glaucoma
than males (adjusted OR = 1.6; 95 % CI = 0.778–3.428;
p = 0.195); and not surprisingly, age was found to be
a significantly strong indicator for the development of
glaucoma in this group (adjusted OR = 1.2; 95 % con-
fidence interval = 1.078–1.157; p < 0.001).












61.1 (±12.6) 56.5 (±10.4) 0.124
Gender Male 52 (59.8) 69 (73.4) 0.052
Female 35 (40.2) 25 (26.6)
Systemic Diseases
Diabetes mellitus Present 43 (49.4) 37 (39.4) 0.173
Hypertension Present 42 (48.3) 36 (38.3) 0.176
Coronary artery
disease
Present 5 (5.7) 2 (2.1) 0.264




Yes 11 (12.6) 2 (2.1) 0.006
Smoking Yes 36 (41.4) 29 (30.9) 0.142
Awareness to
glaucoma
Yes 14 (16.1) 0.0 (0.0) <0.0001
Table 2 Comparison of genotype and allele distribution of SNP











A/A 69 (79.3) 78 (83) - - -
A/C 18 (20.7) 16 (17) 1.3 [0.563–2.891] 0.571
Allele
A 156 (89.7) 173 (91.5) - - -
C 18 (10.3) 16 (8.5) 1.3 [0.578–2.713] 0.591
Table 3 Effect of genotypes on demographic and other clinical
characteristics among POAG cases








Age in years, Mean (±SD) - 61.5 (13.2) 59.8 (9.9) 0.644
Gender Male 43 (62.3) 9 (50.0) 0.4212
Female 26 (37.7) 9 (50.0) -
Systemic Diseases
Diabetes mellitus Present 37 (53.6) 6 (33.3) 0.205
Hypertension Present 34 (49.3) 8 (44.4) 0.920
Coronary artery disease Present 4 (5.8) 1 (5.6) 0.971
Hypercholesterolemia Present 9 (13.0) 4 (22.2) 0.357
Health Awareness / Behavior
Family history of glaucoma Yes 9 (13) 2 (11.1) 0.988
Smoking Yes 26 (38.2) 10 (55.6) 0.272




- 35.0 (7.5) 34.8 (8.0) 0.778
Cup/disc ratio, Mean (±SD) - 0.72 (0.18) 0.7 (0.2) 0.740
Number of anti-glaucoma
medications, Mean (±SD)
- 2.9 (0.7) 2.8 (0.6) 0.765
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Discussion
Given the complexity and genetic mutational hetero-
geneity of POAG recent GWASs have identified a
number of polymorphisms in multiple loci/genes in-
cluding caveolin (CAV1/CAV2) [12], atonal homolog 7
(ATOH7) [13], sin oculis homeobox (SIX1/SIX6) [14],
cyclin-dependent kinase inhibitor 2B antisense RNA 1
(CDKN2B-AS1) [6, 14] and TMCO1 [6, 14] that may
contribute to the development and/or progression of
POAG in various ethnic groups. In this study, we in-
vestigated whether SNP rs7555523 (A > C) in TMCO1
gene is a risk factor for POAG in a Saudi cohort.
Genetic variation in TMCO1 has been associated with
POAG [6, 15]. The association of the TMCO1 locus with
POAG has been replicated in another GWAS [7]. Simi-
larly, TMCO1 loci (including rs7555523) showed signifi-
cant association with POAG and high-tension glaucoma
in a Han Chinese population [16]. However, conflicting
results have been observed for populations of African
ancestry [17, 18]. The frequency distribution of poly-
morphism(s) is known to vary significantly across the
different ethnic groups. SNP rs7555523 has been re-
ported to have a minor allele frequency (MAF) of 0.12
in Caucasians [7], 0.016 in Han Chinese [16] and 0.132
in Sub-Saharan African [http://www.ncbi.nlm.nih.gov/
projects/SNP/snp_ref.cgi?rs=7555523]. The MAF ob-
served in our POAG Saudi cohort was 0.103 which is
slightly lower than the Caucasians and Africans, but
much higher than the Han Chinese (Asians). However,
in contrast to the Caucasian and Chinese studies, the
genotype and allele frequency of rs7555523 were not
found to be an independent risk factor of POAG in our
cohort indicating that this SNP may not have a signifi-
cant role in Saudi POAG as compared to Caucasians
and Chinese.
Family history, aging, cigarette smoking, diabetes and
hypertension are well recognized risk factors of POAG
[19, 20]. Sharma et al. has shown that POAG patients
carrying the risk allele of SNP rs4656461 near the
TMCO1 gene tend to have an earlier age at diagnosis of
glaucoma [10]. However, in our study, although the
subjects with mutant heterozygous (A/C) genotypes
were found to be slighter younger but the difference was
statistically non-significant. Likewise, SNP rs7555523 is
located in a region which has been previously suggested
to be linked with blood pressure [21]. In our study,
however, none of the systemic diseases including hyper-
tension were found to be significantly associated with
this genotype.
TMCO1 is a highly evolutionary conserved gene of
largely unknown function [8, 22]. A homozygous frame-
shift mutation in TMCO1 has been associated with a
rare recessive syndrome known as “TMCO1 defect syn-
drome” consisting of craniofacial dysmorphism, skeletal
anomalies and mental retardation [22]. It is still unclear
how this gene contributes to the pathogenesis of glau-
coma. Studies suggest that TMCO1 may contribute to
POAG through the pathway of IOP elevation [7, 16].
However, we did not find any significant association
between heterozygous (A/C) genotype and clinical indi-
ces important for glaucoma such as IOP, cup-to-disc
ratio and number of anti-glaucoma medications. It is
noteworthy to mention here that TMCO1 interacts with
another known POAG susceptibility gene, CAV1 via the
von Hippel-Lindau (VHL) tumor suppressor protein-
containing E3 ubiquitin ligase [7, 23]; and we have previ-
ously shown that SNP rs4236601 in CAV1/CAV2 is not
a risk factor for POAG in Saudi population [24], plaus-
ibly suggesting that TMCO1 may not have an important
role in POAG pathogenesis in this population. However,
considering the small sample size in this study and
the fact that there was no homozygous mutant (C/C)
genotype observed in our sample population these ob-
servations may require further validation in a large
sample population.
Conclusion
Our study was unable to replicate the findings of
previous association reported for variant rs7555523 in
TMCO1 with POAG and important clinical indices such
as IOP and cup/disc ratio indicating that this SNP is not
a risk factor for POAG or its important clinical indices
in the Saudi cohort.
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